T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing...
Staff
JenaValve Announces First Case for Inclusion in JENA-VAD Registry
Registry seeks to evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System in patients with left ventricular...
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE)...
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Florida
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 16, 2024...
Neural Therapeutics Announces Changes to Board of Directors and Completion of Debt Settlement
Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company...
Hisense Unveils Award-Winning 110-Inch MiniLED TV in MEA
DUBAI, UAE, Dec. 16, 2024 /PRNewswire/ -- Hisense is thrilled to announce the launch of its groundbreaking 110-inch MiniLED TV,...
NeoPhore appoints Michael Shih as Chief Executive Officer
Highly experienced corporate development leader with a track record of international pharma and biotech deal-makingNew CEO to drive growth strategy to maximise...
Promise Bio Emerges from Stealth with $8.3M Seed Investment to Transform Precision Medicine for Immune-Mediated Diseases
Company unveils breakthrough platform that integrates epiproteomics and AI to identify predictive biomarkers for personalized treatments and support drug development...
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU...
Seoul to Host 1,040㎡ ‘Seoul Pavilion’ at CES 2025: “Advancing Global Success for Seoul Startups”
SEOUL, South Korea, Dec. 15, 2024 /PRNewswire/ -- The Seoul Metropolitan Government announced on December 9 that it will operate its...
Best Legal Steroids: Effective Bodybuilding Steroid Alternatives for Muscle Growth
Closest thing to real steroids to use for cutting and bulking in the bodybuilding industry SAN FRANCISCO, CA / ACCESSWIRE...
Noise Detection And Monitoring Market size to increase by USD 7.19 Billion between 2023 to 2028, Market Segmentation by End-user, Component, Geography , Technavio
NEW YORK, Dec. 15, 2024 /PRNewswire/ -- The global noise detection and monitoring market size is estimated to grow by...
Online Therapy Services Market , 42% of Growth to Originate from North America, Technavio
NEW YORK, Dec. 15, 2024 /PRNewswire/ -- The global online therapy services market size is estimated to grow by USD 16.16 billion...
Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board
Vote “FOR” All Four Kellner Group Nominees Today on Gold Card for Urgently Needed Change Kellner Group Owns 5.04% of...
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs
Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and...
Central Florida Foot & Ankle Institute Announces Strategic Partnership With Dr. Kevin Tootle, DPM, FACFAS
CFL Foot & Ankle Institute Lake Mary, FL - Innovative Foot & Ankle Mount Dora, FL ORLANDO, FLORIDA / ACCESSWIRE...
Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions relating to the review of Novo Holdings A/S’s...
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”)...
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinomaWALTHAM, Mass., Dec. 13, 2024 (GLOBE...
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the...